Metraipolis › archive › dc_e2e8dd35f262

Accelerating cancer therapy review: a cross-sectional analysis of expedited approval in China, 2005-2021 — Europe PMC PMID:41699553

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41699553
DOI
10.1186/s12885-[numero omesso]-1
License (as archived)
solo-consultazione
Archived
2026-11-05T19:08:28.650Z
SHA-256 of the archived text
36da2fa9a0b07e62700568d2e696c5523a512368eb3f8abcba4489199bf9bccd
Stable URL of this page
https://metraipolis.com/documento/dc_e2e8dd35f262

How to cite

Accelerating cancer therapy review: a cross-sectional analysis of expedited approval in China, 2005-2021 — Europe PMC PMID:41699553 — Europe PMC (en), https://europepmc.org/article/MED/41699553 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e2e8dd35f262 (Metraipolis archive dc_e2e8dd35f262, sha256 36da2fa9a0b07e62700568d2e696c5523a512368eb3f8abcba4489199bf9bccd)
BibTeX
@misc{dce2e8dd35f262,
  title = {Accelerating cancer therapy review: a cross-sectional analysis of expedited approval in China, 2005-2021 — Europe PMC PMID:41699553},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41699553},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e2e8dd35f262; sha256 36da2fa9a0b07e62700568d2e696c5523a512368eb3f8abcba4489199bf9bccd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41699553. Agents can read the archived copy with the MCP tool read_document.